IDL Biotech AB operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares IDL Biotech AB with three other
pharmaceutical manufacturers in Europe:
sales of 8.20 million Euro [US$9.56 million]
(4.20 million Euro [US$4.90 million]
of which 53%
was Product sales (own and third party)), and
RTA Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret AS
based in Turkey
(31.81 million Turkish Liras [US$9.01 million]
IDL Biotech AB reported sales of SEK 33.49 million (US$4.06 million)
December of 2016.
increase of 17.5%
versus 2015, when the company's sales were SEK 28.52 million.
Sales at IDL Biotech AB have increased during each of the previous five years
(and since 2011, sales have increased a total of 130%).